Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 225

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment

Open access
Guttman‐Yassky, Emma, Krueger, James G., Lebwohl, Mark G.·2018·Experimental Dermatology

Abstract

Atopic dermatitis (AD) and psoriasis are inflammatory skin diseases that negatively affect patients’ quality of life. Although distinctions exist between these diseases, both are characterized by erythematous, thickened epidermal lesions that vary in intensity and affected body surface area. Early models of aetiology attributed symptoms of both diseases to cutaneous inflammation at lesion sites, but recent studies have established that activated immune mediators in the circulation drive disease severity. Activation of T helper 2 (Th2) and Th22 cells in the circulation appears to be the principal initiator of acute AD pathology, with the emergence of Th1 and Th17/interleukin (IL)‐23 pathway activation marking the transition to a chronic state. The Th17/IL‐23 pathway also has an important role in psoriasis. The role of systemic inflammation in AD and psoriasis is supported by the occurrence of non‐cutaneous comorbidities that affect patients, most of which intensify morbidity and disability associated with lesional skin. Atopic dermatitis is associated with allergic disorders consisting of the “atopic march,” whereas psoriasis is frequently accompanied by psoriatic arthritis. Patients with both disorders are at significantly higher risk of obesity, metabolic disorders, and cardiovascular diseases, all of which feature inflammatory components in their pathology models. These insights have led to novel therapeutics aimed at addressing psoriasis by targeting tumor necrosis factor‐ and Th17‐related cytokine pathways. The success of these agents in psoriasis management is driving new therapeutic approaches for moderate‐to‐severe AD, including agents targeting the Th2 and Th17/Th22 cytokine pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/exd.13336

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 225

Metadata

Authors
Guttman‐Yassky, E., Krueger, J. G., & Lebwohl, M. G.
Venue
Experimental Dermatology
Publisher
Wiley
Published
2017-05-09
Volume
27
Issue
4
Pages
409-417
ISSN
  • 0906-6705 (ISSN-L)
  • 1600-0625
OpenAlex
W2591622655
Cited by
225
References
10
FWCI
22.65
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment. https://app.cochat.ai/papers/10.1111/exd.13336
The paper
Guttman‐Yassky, E., Krueger, J. G., & Lebwohl, M. G. (2018). Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment. Experimental Dermatology. https://doi.org/10.1111/exd.13336

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.